Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic TargetLuika Timmerman, Joe W. Gray, Mercè Padró et al.|Cancer Cell|2013Cited by 571
PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic TransformationKatsutoshi Oda, Frank McCormick, Jennifer Okada et al.|Cancer Research|2008Cited by 193
xCT inhibition sensitizes tumors to γ-radiation via glutathione reductionLara Cobler, Luika Timmerman|Oncotarget|2018Cited by 71